Wolfram Nothaft

Wolfram Nothaft, MD, currently serves as Head of Asset Leadership at AbbVie since September 2024 and also holds the position of Deputy Chair of the Board at Kupando GmbH since May 2021. Prior experience includes Chief Medical Officer and Executive Vice President at Takeda from January 2019 to September 2024, and various leadership roles at Shire from December 2012 to January 2019, including Head of Global Clinical Development. Previous positions also encompass leadership roles in global pharmaceutical research at Abbott, Astellas Pharma US, Takeda Europe R&D Centre, and Hoechst Marion Roussel. Wolfram Nothaft earned a medical degree from FAU Erlangen-Nürnberg, completing an Internal Medicine Residency Program.